BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND CBL, RNF55, 867, ENSG00000110395, C-CBL, CBL2 AND Prognosis
20 results:

  • 1. Racial and ethnic disparities in alcohol-associated liver disease in the United States: A systematic review and meta-analysis.
    Anouti A; Seif El Dahan K; Rich NE; Louissaint J; Lee WM; Lieber SR; Arab JP; Zhang BY; Patel MJ; Thimphittaya C; Díaz LA; Gregory DL; Kozlitina J; VanWagner LB; King AC; Mitchell MC; Singal AG; Cotter TG
    Hepatol Commun; 2024 Apr; 8(4):. PubMed ID: 38497931
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. SERPINE2 promotes liver cancer metastasis by inhibiting c-cbl-mediated EGFR ubiquitination and degradation.
    Zhang S; Jia X; Dai H; Zhu X; Song W; Bian S; Wu H; Chen S; Tang Y; Chen J; Jin C; Zhou M; Xie H; Zheng S; Song P
    Cancer Commun (Lond); 2024 Mar; 44(3):384-407. PubMed ID: 38407942
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Featured lncRNA-based signature for discriminating prognosis and progression of hepatocellular carcinoma.
    Qiu H; Jiang B; Chen Y; Lin Z; Zheng W; Cao X
    J Appl Genet; 2024 May; 65(2):355-366. PubMed ID: 38347289
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Development of a machine learning-based model for predicting risk of early postoperative recurrence of hepatocellular carcinoma.
    Zhang YB; Yang G; Bu Y; Lei P; Zhang W; Zhang DY
    World J Gastroenterol; 2023 Nov; 29(43):5804-5817. PubMed ID: 38074914
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. An evaluation of 20-year survival of radiofrequency ablation for hepatocellular carcinoma as first-line treatment.
    Bai XM; He ZH; Wu H; Yang W; Wang S; Zhang ZY; Wu W; Yan K; Chen MH; Nahum Goldberg S
    Eur J Radiol; 2023 Nov; 168():111094. PubMed ID: 37738836
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [The analysis of long-term prognostic factors after laparoscopic liver resection for intrahepatic cholangiocarcinoma and establishment of survival Nomogram model].
    Shen ZF; Chen C; Geng ZM; Mao XH; Li JD; Song TQ; Sun CD; Wu H; Cheng ZJ; Lin RX; He Y; Zhai WL; Tang D; Tang ZH; Liang X
    Zhonghua Wai Ke Za Zhi; 2022 Oct; 60(10):939-947. PubMed ID: 36207983
    [No Abstract]    [Full Text] [Related]  

  • 7. Prediction of post-hepatectomy liver failure and long-term prognosis after curative resection of hepatocellular carcinoma using liver stiffness measurement.
    Chen X; Kuang M; Hu ZH; Peng YH; Wang N; Luo H; Yang P
    Arab J Gastroenterol; 2022 May; 23(2):82-88. PubMed ID: 35120839
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Recurrent colorectal liver metastasis patients could benefit from repeat hepatic resection.
    Liu W; Liu JM; Wang K; Wang HW; Xing BC
    BMC Surg; 2021 Aug; 21(1):327. PubMed ID: 34399728
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The value of the signal intensity of peritumoral tissue on Gd-EOB-DTPA dynamic enhanced MRI in assessment of microvascular invasion and pathological grade of hepatocellular carcinoma.
    Wang LL; Li JF; Lei JQ; Guo SL; Li JK; Xu YS; Dou Y
    Medicine (Baltimore); 2021 May; 100(20):e25804. PubMed ID: 34011043
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Risk factors and predictors for tumor site origin in metastatic adenocarcinoma of unknown primary site.
    Li X; Shao Y; Sheng L; Zhu J; Wang Z; Guo K; Sun L
    Cancer Med; 2021 Feb; 10(3):974-988. PubMed ID: 33405390
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The 14-3-3σ protein promotes HCC anoikis resistance by inhibiting EGFR degradation and thereby activating the EGFR-dependent ERK1/2 signaling pathway.
    Song J; Liu Y; Liu F; Zhang L; Li G; Yuan C; Yu C; Lu X; Liu Q; Chen X; Liang H; Ding Z; Zhang B
    Theranostics; 2021; 11(3):996-1015. PubMed ID: 33391517
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Association between prehospital prognostic factors and out-of-hospital cardiac arrest: Effect of rural-urban disparities.
    Hsu YC; Wu WT; Huang JB; Lee KH; Cheng FJ
    Am J Emerg Med; 2021 Aug; 46():456-461. PubMed ID: 33143958
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [Value of serum alpha-fetoprotein for the prognostic evaluation of hepatitis B virus-related acute-on-chronic liver failure treated with artificial liver].
    Qin S; Tang SH; Wang XH; Wang XP; Sun MY; Wu XL; Zeng WZ
    Zhonghua Gan Zang Bing Za Zhi; 2020 Jan; 28(1):69-72. PubMed ID: 32023703
    [No Abstract]    [Full Text] [Related]  

  • 14. The Ratio of C-Reactive Protein/Albumin is a Novel Inflammatory Predictor of Overall Survival in Cisplatin-Based Treated Patients with Metastatic Nasopharyngeal Carcinoma.
    Sun P; Chen C; Xia Y; Bi X; Liu P; Zhang F; Yang H; An X; Jiang W; Wang F
    Dis Markers; 2017; 2017():6570808. PubMed ID: 28676731
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Application of Indocyanine Green (ICG) Detection in Evaluating Early prognosis in Patients with Fatty liver Disease After liver Transplantation.
    Wang W; Zhao Q; Hu A; He X; Zhu X
    Ann Transplant; 2017 Apr; 22():208-214. PubMed ID: 28396579
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Expression and Prognostic Role of FHIT, Fibronectin, and PTEN in Hepatocellular Carcinoma.
    Zhang MJ; Yan Q; Zhang GL; Wie YH; Yuan WB; Xu W; Huang LF
    Clin Lab; 2016 Jul; 62(7):1255-1264. PubMed ID: 28164627
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Long-Term Outcomes and Prognostic Factors in Advanced Gallbladder cancer: Focus on the Advanced T Stage.
    Chen C; Geng Z; Shen H; Song H; Zhao Y; Zhang G; Li W; Ma L; Wang L
    PLoS One; 2016; 11(11):e0166361. PubMed ID: 27846279
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Peritumoral cbl is a strong independent prognostic marker after curative resection of hepatocellular carcinoma.
    Zhang JB; Zhang B; Guo L; Lin ZH; Li XQ; Guo K; Sun HC; Ye QH
    Oncotarget; 2015 Nov; 6(37):40223-34. PubMed ID: 26474280
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Diagnostic values of alpha-fetoprotein, dickkopf-1, and osteopontin for hepatocellular carcinoma.
    Ge T; Shen Q; Wang N; Zhang Y; Ge Z; Chu W; Lv X; Zhao F; Zhao W; Fan J; Qin W
    Med Oncol; 2015 Mar; 32(3):59. PubMed ID: 25652109
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. ASXL1 but not TET2 mutations adversely impact overall survival of patients suffering systemic mastocytosis with associated clonal hematologic non-mast-cell diseases.
    Damaj G; Joris M; Chandesris O; Hanssens K; Soucie E; Canioni D; Kolb B; Durieu I; Gyan E; Livideanu C; Chèze S; Diouf M; Garidi R; Georgin-Lavialle S; Asnafi V; Lhermitte L; Lavigne C; Launay D; Arock M; Lortholary O; Dubreuil P; Hermine O
    PLoS One; 2014; 9(1):e85362. PubMed ID: 24465546
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.